| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Physiology and of Medicine, Dartmouth Medical School, Lebanon, New Hampshire 03756-0001
Address all correspondence and requests for reprints to: Valerie Anne Galton, Departments of Physiology and of Medicine, Dartmouth Medical School, 1 Medical Center Drive, Borwell Building, Lebanon, New Hampshire 03756-0001. E-mail: val.galton{at}dartmouth.edu.
The deiodinase types 2 and 3 (D2, D3), which convert T4 to active and inactive metabolites, respectively, are expressed in the rodent uterus and highly induced during pregnancy. To examine the factors regulating the expression of these enzymes in this tissue, we studied D2 and D3 activity in pregnant rats, in pseudopregnant rats before and after the induction of artificial decidualization, and in ovariectomized rats treated with 17ß-estradiol (E2) and/or progesterone (P). Our results demonstrate that induction of D3 activity begins immediately after implantation and increases markedly over the next 72 h. A similar time course and magnitude of D3 induction is noted in the artificially decidualized uterus in pseudopregnant rats, whereas only minimal increases in activity are observed in the nondecidualized control uterine horns in the same animal. In contrast, D2 activity is not induced by a decidualization stimulus. In spontaneously cycling female rats, both D2 and D3 were observed to be 3- to 8-fold higher in proestrus, compared with diestrus. Furthermore, levels of D2 and D3 activity were greatly increased in ovariectomized rats given E2 and P in various combinations. D2 activity was stimulated primarily by E2, whereas E2 and P acted synergistically to increase D3 activity. These results demonstrate that E2 and P regulate thyroid hormone metabolism in the uterus, and that the implantation process is a potent stimulus for the induction of D3 activity in this organ. Such precise and profound changes in deiodinase expression are likely to play important physiological roles in fetal development and may influence uterine function.
This article has been cited by other articles:
 |
|
 |
|
  R. Grozovsky, S. Ribich, M. L. Rosene, M. A. Mulcahey, S. A. Huang, M. E. Patti, A. C. Bianco, and B. W. Kim Type 2 Deiodinase Expression Is Induced by Peroxisomal Proliferator-Activated Receptor-{gamma} Agonists in Skeletal Myocytes Endocrinology, April 1, 2009; 150(4): 1976 - 1983. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.L. Greathouse, J.D. Cook, K. Lin, B.J. Davis, T.D. Berry, T.G. Bredfeldt, and C.L. Walker Identification of Uterine Leiomyoma Genes Developmentally Reprogrammed by Neonatal Exposure to Diethylstilbestrol Reproductive Sciences, October 1, 2008; 15(8): 765 - 778. [Abstract] [PDF]
|
|
|
|
 |
|
 K. Nagayama, S. Sasaki, A. Matsushita, K. Ohba, H. Iwaki, H. Matsunaga, S. Suzuki, H. Misawa, K. Ishizuka, Y. Oki, et al. Inhibition of GATA2-dependent transactivation of the TSH{beta} gene by ligand-bound estrogen receptor {alpha} J. Endocrinol., October 1, 2008; 199(1): 113 - 125. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. H. A. Kester, G. G. J. M. Kuiper, R. Versteeg, and T. J. Visser Regulation of Type III Iodothyronine Deiodinase Expression in Human Cell Lines Endocrinology, December 1, 2006; 147(12): 5845 - 5854. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. K. Alexander, E. Marqusee, J. Lawrence, P. Jarolim, G. A. Fischer, and P. R. Larsen Timing and Magnitude of Increases in Levothyroxine Requirements during Pregnancy in Women with Hypothyroidism N. Engl. J. Med., July 15, 2004; 351(3): 241 - 249. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. P. Carvalho Modulation of Uterine Iodothyronine Deiodinases--A Critical Event for Fetal Development? Endocrinology, October 1, 2003; 144(10): 4250 - 4252. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
